Navigation Links
Nanotechnology to Increase Cost Efficiency by Streamlining Global Medical Devices Value Chain

SANTA CLARA, Calif., Dec. 21, 2016 /PRNewswire/ -- Nanotechnology-based medical devices reduce costs across supply and demand value chains, as they firmly place the bargaining power in the hands of large medical device manufacturing companies. By incorporating nanotechnology into their products, original equipment manufacturers (OEMs) can streamline their supply chain and eliminate business units that hurt their margin. Nanotechnology enables manufacturers to create differentiated, highly precise products that improve the overall quality of life for patients, which opens up the scope for their commercialization.

"Owing to the significant commercialization potential of nano-materials, large medical device companies have partnered with university spin-offs and research institutes to co-create solutions that improve the effectiveness of therapies," said Frost & Sullivan TechVision Industry Analyst Arjunvasan Ambigapathy. "Researchers particularly focus on developing products for high-growth medical device sectors such as wearables, point-of-care diagnostics, advanced wound care, and drug delivery systems, targeting conditions other than cancer."

Nanotechnology to Achieve Cost Efficiencies within Global Medical Devices Value Chain is part of the TechVision (Microelectronics) Growth Partnership Service program. The study details technology developments in the major medical device segments of drug delivery systems, in vivo imaging, medical implants and in vitro diagnostics. It also evaluates the outcomes of strategic partnerships with start-ups and research institutions, and explores investment opportunities in nanotechnology research programs.

Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.

There are few impediments to the rapid commercialization and adoption of nanotechnology during development of medical devices. Even the challenges inherent in the scaling up of nanocoating technologies and nano-functionalization of surfaces for the improved performance of devices are almost negligible.

"Meanwhile, initiatives by global regulatory agencies to encourage the use of nanotechnology in medical devices are likely to have a big impact on the large-scale commercialization of nano-based medical devices," noted Ambigapathy.

Overall, companies that can out-innovate their peers and are quick to form strategic partnerships with industry majors are best poised to succeed early.

About TechVision

Frost & Sullivan's global TechVision practice is focused on innovation, disruption and convergence, and provides a variety of technology-based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link:

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Nanotechnology to Achieve Cost Efficiencies within Global Medical Devices Value Chain

Mariana Fernandez
Corporate Communications – North America
P: +54 11 4778 3540
F: +54 11 4777 0071

Twitter: @TechVision_FS


To view the original version on PR Newswire, visit:

SOURCE Frost & Sullivan
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Pharmaceutical Excipients Market 2016-2021 - Advances in Nanotechnology Imparting New Functions to Pharmaceutical Excipients - Research and Markets
2. Nanotechnology Drug Delivery Market to Touch US$ 11.9 Billion in 2023: Transparency Market Research
3. Nanotechnology Accelerates the Evolution of Precision Medicine, Finds Frost & Sullivan
4. Microscopy Market Growth to 2019 Driven by Nanotechnology and Increasing Federal Support
5. Nanotechnology in Medical Devices Market Worth $8.5 Billion by 2019
6. Global Microscopy (Semiconductor, Life Science, Nanotechnology) Market - Forecast to 2019
7. Nanotechnology Venture Targets Arterial, Heart and Kidney Diseases
8. IBM Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery
9. Femtosecond Lasers for Cataract Surgery: Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018
10. Global Market Study on Pharmaceutical Excipients: Increased Drug Demand in Emerging Asia Pacific Market to Fuel Demand Multi-Functional Excipients
11. Lilly Announces Dividend Increase
Post Your Comments:
(Date:6/16/2019)... United Kingdom (PRWEB) , ... June 15, 2019 ... ... , has just published results of a clinical study on its new ... the company used different nutraceutical capsule and chocolate formulations, which were based on ...
(Date:6/14/2019)... , ... June 14, 2019 ... ... SIMPLY, a forecasting and analytics platform that helps Life Sciences Manufacturers accurately ... problems for Life Sciences business leaders: accurate, automated forecasting of rebates and ...
(Date:6/13/2019)... ... 2019 , ... Alliance Cost Containment, LLC (ACC) secured $5.8M in ... The $5.8M in savings is in addition to $17.6M saved over the course of ... acquisition in Q4 2019, the client increased their Fortune 500 status in the healthcare ...
Breaking Medicine Technology:
(Date:6/18/2019)... SEATTLE (PRWEB) , ... June 18, 2019 , ... ... company developing non-invasive treatments for cancers and other serious diseases, announced it has ... the EMulate Therapeutics application for Humanitarian Device Exemption (HDE) for the Hælo Pediatric ...
(Date:6/18/2019)... ... June 18, 2019 , ... Intalere, ... announced Steve Einig has joined the organization in the newly created role of ... around market engagement, marketing, strategic events and brand management. , “Steve brings a ...
(Date:6/16/2019)... ... June 16, 2019 , ... ... Holdings executives focusing on scientific research for the advancement of medical marijuana-based pharmaceuticals in ... your local listings for more information. , With two investigational new drug applications ...
(Date:6/13/2019)... ... ... Endometriosis is a painful, inflammatory disease that occurs when tissue grows outside of the uterus. ... Heavy bleeding , Irregular menstruation , Severe cramps , ... latest and newest treatment protocols in dealing with the symptoms of endometriosis. In the past, ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... In Partnership ... free dental services for low-income, underinsured individuals at its Mesquite, TX office on July ... x-rays, fillings, cleanings and extractions . For more information, please visit ...
Breaking Medicine News(10 mins):